AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE
AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE
Approved
DIN Number
02496356
Drug Class
Human
Market Date
Nov 9, 2020
Company
HC
angita pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02496356
AIG Number0251568001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR03 TENOFOVIR DISOPROXIL AND EMTRICITABINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (2)
EMTRICITABINEActive
Strength: 200 MG
Monograph: EMTRICITABINE
TENOFOVIR DISOPROXIL FUMARATEActive
Strength: 300 MG
Monograph: TENOFOVIR DISOPROXIL FUMARATE